Miller TR - Search Results

1

Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.

Lin CW, Miller TR, Witte DG, Bianchi BR, Stashko M, Manelli AM, Frail DE. Lin CW, et al. Among authors: miller tr. Mol Pharmacol. 1995 Jan;47(1):131-9. Mol Pharmacol. 1995. PMID: 7838121

2

Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.

Lin CW, Shiosaki K, Miller TR, Witte DG, Bianchi BR, Wolfram CA, Kopecka H, Craig R, Wagenaar F, Nadzan AM. Lin CW, et al. Among authors: miller tr. Mol Pharmacol. 1991 Mar;39(3):346-51. Mol Pharmacol. 1991. PMID: 1706470

3

Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.

Lin CW, Bianchi BR, Miller TR, Stashko MA, Wang SS, Curzon P, Bednarz L, Asin KE, Britton DR. Lin CW, et al. Among authors: miller tr. J Pharmacol Exp Ther. 1996 Mar;276(3):1022-9. J Pharmacol Exp Ther. 1996. PMID: 8786531

4

Cloning and characterization of the monkey histamine H3 receptor isoforms.

Strakhova MI, Fox GB, Carr TL, Witte DG, Vortherms TA, Manelli AM, Miller TR, Yao BB, Brioni JD, Esbenshade TA. Strakhova MI, et al. Among authors: miller tr. Eur J Pharmacol. 2008 Dec 28;601(1-3):8-15. doi: 10.1016/j.ejphar.2008.10.026. Epub 2008 Oct 21. Eur J Pharmacol. 2008. PMID: 18977214

5

Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N epsilon)-amide residues.

Shiosaki K, Lin CW, Kopecka H, Craig RA, Bianchi BR, Miller TR, Witte DG, Stashko M, Nadzan AM. Shiosaki K, et al. Among authors: miller tr. J Med Chem. 1992 May 29;35(11):2007-14. doi: 10.1021/jm00089a010. J Med Chem. 1992. PMID: 1375964

6

Synthesis and biological activity of CCK heptapeptide analogues. Effects of conformational constraints and standard modifications on receptor subtype selectivity, functional activity in vitro, and appetite suppression in vivo.

Holladay MW, Bennett MJ, Tufano MD, Lin CW, Asin KE, Witte DG, Miller TR, Bianchi BR, Nikkel AL, Bednarz L, et al. Holladay MW, et al. Among authors: miller tr. J Med Chem. 1992 Aug 7;35(16):2919-28. doi: 10.1021/jm00094a001. J Med Chem. 1992. PMID: 1501220

7

Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.

Lin CW, Bianchi BR, Miller TR, Witte DG, Wolfram CA. Lin CW, et al. Among authors: miller tr. Am J Physiol. 1992 Jun;262(6 Pt 1):G1113-20. doi: 10.1152/ajpgi.1992.262.6.G1113. Am J Physiol. 1992. PMID: 1616041

8

Boc-CCK-4 derivatives containing side-chain ureas as potent and selective CCK-a receptor agonists.

Shiosaki K, Lin CW, Kopecka H, Tufano MD, Bianchi BR, Miller TR, Witte DG, Nadzan AM. Shiosaki K, et al. Among authors: miller tr. J Med Chem. 1991 Sep;34(9):2837-42. doi: 10.1021/jm00113a023. J Med Chem. 1991. PMID: 1716682

9

A71378: a CCK agonist with high potency and selectivity for CCK-A receptors.

Lin CW, Holladay MW, Witte DG, Miller TR, Wolfram CA, Bianchi BR, Bennett MJ, Nadzan AM. Lin CW, et al. Among authors: miller tr. Am J Physiol. 1990 Apr;258(4 Pt 1):G648-51. doi: 10.1152/ajpgi.1990.258.4.G648. Am J Physiol. 1990. PMID: 2333977

10

Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).

Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF Jr, Wagenaar F, Nadzan AM. Lin CW, et al. Among authors: miller tr. Mol Pharmacol. 1989 Dec;36(6):881-6. Mol Pharmacol. 1989. PMID: 2601685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

758 results

Search Page

Filters